CD9 regulates proliferation, invasion, migration and radioresistance of esophageal squamous cell carcinoma by activating AKT/GSK3β signaling pathway
CD9 promotes ESCC progression and radioresistance by activating the AKT/GSK3β pathway and holds promise as a potential prognostic biomarker and therapeutic target for ESCC.
Authors
- Huandi Zhou (ORCID: https://orcid.org/0000-0002-2617-6157)
- Zerui Hao (ORCID: https://orcid.org/0000-0001-6458-8120)
- Xiaoying Xue (ORCID: https://orcid.org/0000-0002-4934-2904)
- Yu Wang (ORCID: https://orcid.org/0000-0003-2271-7371)
- Liubing Hou (ORCID: https://orcid.org/0000-0003-2018-8103)
- Ge Zhang (ORCID: https://orcid.org/0000-0002-3116-3246)
- Jiayuan Li (ORCID: https://orcid.org/0000-0002-9850-1668)
Institutions
- Hebei Medical University (CN)
- Second Hospital of Hebei Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-08-08
- DOI
- https://doi.org/10.3389/fonc.2025.1625120
- Primary Topic
- Cell Adhesion Molecules Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Peking University First Hospital
- Peking University